Cleared Traditional

K162987 - FA100 SCCD (Sequential Continuous Contraction Device)

K162987 is an FDA 510(k) clearance for FA100 SCCD (Sequential Continuous Contr..., manufactured by Flowaid Medical Technologies, Corp. The device is a Class 2 Physical Medicine device with product code IPF cleared through the Traditional 510(k) pathway after a 110-day FDA review.

K162987 · Flowaid Medical Technologies, Corp · Physical Medicine device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2017
Decision
110d
Days
Class 2
Risk

K162987 is an FDA 510(k) clearance for the FA100 SCCD (Sequential Continuous Contraction Device). Classified as Stimulator, Muscle, Powered (product code IPF), Class II - Special Controls.

Submitted by Flowaid Medical Technologies, Corp (New York, US). The FDA issued a Cleared decision on February 14, 2017 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5850 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K162987

510(k) Number K162987 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 2016
Decision Date February 14, 2017
Days to Decision 110 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 116d · This submission: 110d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IPF Device Classification - Class 2, Special Controls

Product Code IPF Stimulator, Muscle, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - IPF Stimulator, Muscle, Powered

All 370
Devices cleared under the same product code (IPF) and FDA review panel - the closest regulatory comparables to K162987.
StimSox(TM) System
K171071 · Stimmed, LLC · Aug 2017
EMS100 Tri-Wave Combination Stimulator
K171387 · Elite Medical Supply of New York, LLC · May 2017
geko™ T-2 and geko™ Plus R-2 Neuromuscular Stimulators
K163125 · Firstkind Limited · Apr 2017
Xcite Clinical Station
K160614 · Restorative Therapies, Inc. · Dec 2016
CyMedica e-vive™ System
K163067 · Cymedica Orthopedics, Inc. · Dec 2016
HPM-6000
K160992 · BTL Industries, Inc. · Oct 2016